TearLab

TearLab

Employees:
80
Market Cap:
$6.31 million
Revenue:
$28.01 million
5 Year Trend:
67.5%
Net Income:
$-18.78 million
NASDAQ:
TEAR

TearLab

Employees:
80
Market Cap:
$6.31 million
Revenue:
$28.01 million
5 Year Trend:
67.5%
Net Income:
$-18.78 million
NASDAQ:
TEAR
  • Nov 30 at 6:05 PM
    Glaucoma therapy causing ocular surface disease? Learn more about the importance of managing your glaucoma patients ocular surface: http://bit.ly/2Ai4mwc
  • Nov 27 at 4:26 PM
    Why did you start treating Dry Eye? What tools do you use to diagnose and treat this prevalent disease? Drs. Periman, Mac, and Kontos discuss these questions to help you give symptomatic patients the best care. http://bit.ly/2hY0KoU
  • Nov 21 at 7:02 PM
    Drs. Kabat, Karpecki, & ODell simplify the complications of diagnosing & treating #dryeye: http://bit.ly/2BcrUAT
  • Nov 9 at 5:40 PM
    Learn more about tear osmolarity and its effects on the ocular surface at our booth #824 during #AAO2017 this weekend in New Orleans.

Nov 30, 6:05 PM

Glaucoma therapy causing ocular surface disease? Learn more about the importance of managing your glaucoma patients ocular surface: http://bit.ly/2Ai4mwc

Nov 27, 4:26 PM

Why did you start treating Dry Eye? What tools do you use to diagnose and treat this prevalent disease? Drs. Periman, Mac, and Kontos discuss these questions to help you give symptomatic patients the best care. http://bit.ly/2hY0KoU

Nov 21, 7:02 PM

Drs. Kabat, Karpecki, & ODell simplify the complications of diagnosing & treating #dryeye: http://bit.ly/2BcrUAT

Nov 9, 5:40 PM

Learn more about tear osmolarity and its effects on the ocular surface at our booth #824 during #AAO2017 this weekend in New Orleans.